A rhodium-catalyzed cycloisomerization and oxidation of tethered dienynes for the synthesis of indanes is described. An auxiliary fragmentation/olefination method (also described herein) provides novel access to tethered alkyne-dienoate substrates. The reported method circumvents current limitations in and expands the scope of inverse-demand Diels-Alder-type cycloadditions. Traditional discovery substrates involving malonate-, ether-, and sulfonamide-based tethers are problematic in the current methodology, underscoring the unique virtue of neopentylene-tethered substrates for reaction discovery.
Strategic pairing of ring openings and cycloisomerization provides rapid and efficient "open and shut" entry into sparsely functionalized illudalanes, as exemplified here in the context of a six-step synthesis of alcyopterosin A. Key steps include a tandem ring-opening fragmentation/olefination process for preparing a neopentyl-tethered 1,6-enyne, ring-opening olefination telescoped with alkyne homologation, and Rh-catalyzed oxidative cycloisomerization.
Thiopeptides
are a broad class of macrocyclic, heavily modified
peptide natural products that are unified by the presence of a substituted,
nitrogen-containing heterocycle core. Early work indicated that this
core might be fashioned from two dehydroalanines by an enzyme-catalyzed
aza-[4 + 2] cycloaddition to give a cyclic-hemiaminal intermediate.
This common intermediate could then follow a reductive path toward
a dehydropiperidine, as in the thiopeptide thiostrepton, or an aromatization
path to yield the pyridine groups observed in many other thiopeptides.
Although several of the enzymes proposed to perform this cycloaddition
have been reconstituted, only pyridine products have been isolated
and any hemiaminal intermediates have yet to be observed. Here, we
identify the conditions and substrates that decouple the cycloaddition
from subsequent steps and allow interception and characterization
of this long hypothesized intermediate. Transition state modeling
indicates that the key amide–iminol tautomerization is the
major hurdle in an otherwise energetically favorable cycloaddition.
An anionic model suggests that deprotonation and polarization of this
amide bond by TbtD removes this barrier and provides a sufficient
driving force for facile (stepwise) cycloaddition. This work provides
evidence for a mechanistic link between disparate cyclases in thiopeptide
biosynthesis.
Thiazole-containing
pyritides (thiopeptides) are ribosomally synthesized
and post-translationally modified peptides (RiPPs) that have attracted
interest owing to their potent biological activities and structural
complexity. The class-defining feature of a thiopeptide is a six-membered,
nitrogenous heterocycle formed by an enzymatic [4 + 2]-cycloaddition.
In rare cases, piperidine or dehydropiperidine (DHP) is present; however,
the aromatized pyridine is considerably more common. Despite significant
effort, the mechanism by which the central pyridine is formed remains
poorly understood. Building on our recent observation of the Bycroft–Gowland
intermediate (i.e., the direct product of the [4 + 2]-cycloaddition),
we interrogated thiopeptide pyridine synthases using a combination
of targeted mutagenesis, kinetic assays, substrate analogs, enzyme–substrate
cross-linking, and chemical rescue experiments. Collectively, our
data delineate roles for several conserved residues in thiopeptide
pyridine synthases. A critical tyrosine facilitates the final aromatization
step of pyridine formation. This work provides a foundation for further
exploration of the [4 + 2]-cycloaddition reaction and future customization
of pyridine-containing macrocyclic peptides.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.